Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Methicillin-Resistant Staphylococcus aureus: HELP
G. Ralph Corey
Based on 23 articles published since 2007
||||
Expertise Level
The expertise of G. Ralph Corey ranks in the Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Corey, G R   ·   Corey, G Ralph
Work Locations
Details
Most likely:    Duke University   Contact    
2017
  • Theravance Biopharma US, Inc., South San Francisco, CA, USA. Electronic address: · Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Section of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina. · Theravance Biopharma US, Inc., South San Francisco, CA, USA. · Pubmed 28038840
2015
  • Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina. Electronic address: · JMI Laboratories, North Liberty, IA, USA. · Division of Infectious Diseases, Duke Clinical Research Institute, Durham, NC, USA; Duke University Medical Center, Durham, NC, USA. Electronic address: · Pubmed 25583130
  • Health Economics and Outcomes Research, Merck & Co., Inc., 2000 Galloping Road, Kenilworth, NJ, 07033, USA. · Global Center for Scientific Affairs, Merck Research Laboratories, Merck & Co., Inc, Kenilworth, NJ, USA. · Department of Medicine, Duke University Health System, Durham, NC, USA. · University of Texas at Austin Dell Medical School, Austin, TX, USA. · Albert Einstein College of Medicine Montefiore Medical Center, Bronx, NY, USA. · Infectious Diseases Research, William Beaumont Hospital, Royal Oak, MI, USA. · Medical Research, Mercy Saint Vincent Medical Center, Toledo, OH, USA. · JM Still Burn Center at Doctors Hospital, Augusta, GA, USA. · Northeast Iowa Medical Education Foundation, Waterloo, IA, USA. · Pharmacy and Medicine, University of New Mexico, Albuquerque, NM, USA. · Department of Infectious Diseases, Ochsner Clinic Foundation, New Orleans, LA, USA. · Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA. · Department of Emergency Medicine, Nassau University Medical Center, East Meadow, NY, USA. · Albany College of Pharmacy and Health Sciences, Albany, NY, USA. · Pubmed 26547411
2014
  • From Duke University Medical Center, Durham, NC (G.R.C.); Sunrise Hospital and Medical Center, Las Vegas (H.K.); Sharp Chula Vista Medical Center, Chula Vista (P.M., W.O.), and Sharp Grossmont Hospital, San Diego (J.S.O.) - both in California; MV Hospital and Research Center, Lucknow (S. Gupta), and Inamdar Multispecialty Hospital, Pune (A. Porwal) - both in India; Orlando Health, Orlando, FL (P.G.); and South Jersey Infectious Disease, Somers Point (C.L.), and the Medicines Company, Parsippany (A. Perez, S. Good, H.J., G.M.) - both in New Jersey. · Pubmed 24897083
2011
  • Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 21546623
2010
  • Division of Infectious Diseases, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA. · Pubmed 21115454
2009
  • Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 19374581
2012
  • Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina. · Pubmed 22869571
  • Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina. · Pubmed 22416054
2009
  • Division of Infectious Diseases, Duke Clinical Research Institute, Durham, North Carolina, USA. · Pubmed 19561492
  • Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. · Pubmed 19846653
  • Duke Clinical Research Institute, Durham, North Carolina, USA. · Pubmed 19811099
2008
  • Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina 27710, USA. · Pubmed 18596141
Probable:    Sharp Healthcare      
2014
  • From Duke University Medical Center, Durham, NC (G.R.C.); Sunrise Hospital and Medical Center, Las Vegas (H.K.); Sharp Chula Vista Medical Center, Chula Vista (P.M., W.O.), and Sharp Grossmont Hospital, San Diego (J.S.O.) - both in California; MV Hospital and Research Center, Lucknow (S. Gupta), and Inamdar Multispecialty Hospital, Pune (A. Porwal) - both in India; Orlando Health, Orlando, FL (P.G.); and South Jersey Infectious Disease, Somers Point (C.L.), and the Medicines Company, Parsippany (A. Perez, S. Good, H.J., G.M.) - both in New Jersey. · Pubmed 24897083
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 23 total) written by G. Ralph Corey about Methicillin-Resistant Staphylococcus aureus:

  • Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolates. 2017
  • Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA. 2015
  • An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection. 2015
  • Methicillin-resistant Staphylococcus aureus: an evolving pathogen. 2014
  • A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study. 2014
  • Single-dose oritavancin in the treatment of acute bacterial skin infections. 2014
  • TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections. 2012
  • Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections. 2012
  • Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia. 2011
  • Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections. 2011
Show List of Full Article Records
Google Searches

Learn more about G. Ralph Corey using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Duke University
Sharp Healthcare
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Duke University
2017
  • Theravance Biopharma US, Inc., South San Francisco, CA, USA. Electronic address: · Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Section of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina. · Theravance Biopharma US, Inc., South San Francisco, CA, USA. · Pubmed 28038840
2015
  • Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina. Electronic address: · JMI Laboratories, North Liberty, IA, USA. · Division of Infectious Diseases, Duke Clinical Research Institute, Durham, NC, USA; Duke University Medical Center, Durham, NC, USA. Electronic address: · Pubmed 25583130
  • Health Economics and Outcomes Research, Merck & Co., Inc., 2000 Galloping Road, Kenilworth, NJ, 07033, USA. · Global Center for Scientific Affairs, Merck Research Laboratories, Merck & Co., Inc, Kenilworth, NJ, USA. · Department of Medicine, Duke University Health System, Durham, NC, USA. · University of Texas at Austin Dell Medical School, Austin, TX, USA. · Albert Einstein College of Medicine Montefiore Medical Center, Bronx, NY, USA. · Infectious Diseases Research, William Beaumont Hospital, Royal Oak, MI, USA. · Medical Research, Mercy Saint Vincent Medical Center, Toledo, OH, USA. · JM Still Burn Center at Doctors Hospital, Augusta, GA, USA. · Northeast Iowa Medical Education Foundation, Waterloo, IA, USA. · Pharmacy and Medicine, University of New Mexico, Albuquerque, NM, USA. · Department of Infectious Diseases, Ochsner Clinic Foundation, New Orleans, LA, USA. · Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA. · Department of Emergency Medicine, Nassau University Medical Center, East Meadow, NY, USA. · Albany College of Pharmacy and Health Sciences, Albany, NY, USA. · Pubmed 26547411
2014
  • From Duke University Medical Center, Durham, NC (G.R.C.); Sunrise Hospital and Medical Center, Las Vegas (H.K.); Sharp Chula Vista Medical Center, Chula Vista (P.M., W.O.), and Sharp Grossmont Hospital, San Diego (J.S.O.) - both in California; MV Hospital and Research Center, Lucknow (S. Gupta), and Inamdar Multispecialty Hospital, Pune (A. Porwal) - both in India; Orlando Health, Orlando, FL (P.G.); and South Jersey Infectious Disease, Somers Point (C.L.), and the Medicines Company, Parsippany (A. Perez, S. Good, H.J., G.M.) - both in New Jersey. · Pubmed 24897083
2011
  • Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 21546623
2010
  • Division of Infectious Diseases, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA. · Pubmed 21115454
2009
  • Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 19374581
2012
  • Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina. · Pubmed 22869571
  • Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina. · Pubmed 22416054
2009
  • Division of Infectious Diseases, Duke Clinical Research Institute, Durham, North Carolina, USA. · Pubmed 19561492
  • Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. · Pubmed 19846653
  • Duke Clinical Research Institute, Durham, North Carolina, USA. · Pubmed 19811099
2008
  • Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina 27710, USA. · Pubmed 18596141
Sharp Healthcare
2014
  • From Duke University Medical Center, Durham, NC (G.R.C.); Sunrise Hospital and Medical Center, Las Vegas (H.K.); Sharp Chula Vista Medical Center, Chula Vista (P.M., W.O.), and Sharp Grossmont Hospital, San Diego (J.S.O.) - both in California; MV Hospital and Research Center, Lucknow (S. Gupta), and Inamdar Multispecialty Hospital, Pune (A. Porwal) - both in India; Orlando Health, Orlando, FL (P.G.); and South Jersey Infectious Disease, Somers Point (C.L.), and the Medicines Company, Parsippany (A. Perez, S. Good, H.J., G.M.) - both in New Jersey. · Pubmed 24897083
7 Other Locations Show
Yearly article counts 010230253520
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.